输卵管–卵巢脓肿误诊为卵巢恶性肿瘤一例
A Case of Tubo-Ovarian Abscess Disguising as Ovarian Malignancy
DOI: 10.12677/ACM.2022.125705, PDF,    科研立项经费支持
作者: 焦玉雪*, 冷 喆, 赵 婕, 黄 煜#:青岛大学附属妇女儿童医院,山东 青岛
关键词: 附件包块卵巢恶性肿瘤输卵管–卵巢脓肿盆腔炎性疾病Adnexal Mass Ovarian Malignancy Tubo-Ovarian Abscess Pelvic Inflammatory Disease
摘要: 病史摘要:患者,女,48岁,因“下腹痛2周,扪及盆腔包块1周”就诊于我院。患者2周前经期出现下腹隐痛,伴腹泻,无发热,无腹胀,无异常阴道流液等不适。腹泻症状持续3天后自行好转。1周前患者扪及下腹部包块,质硬,平脐,伴肛门坠胀感。影像学检查提示:卵巢恶性肿瘤可能性大。排除手术禁忌后行手术治疗,术中诊断为:输卵管–卵巢脓肿。术后予以抗生素抗感染治疗。专科检查:阴道内见少许白色分泌物,无腥臭味;宫颈光滑,质韧,盆腔扪及实性包块,大小约20*20 cm,双侧达盆壁,上极平脐,下极达子宫直肠陷凹,活动性差,压痛明显,未扪及双侧附件区。直肠指诊:进指3 cm处可触及质硬包块,活动度差,界限不清,凸向直肠,退指指套无血染。诊断方法:妇科超声、盆腔核磁共振等影像学检查,肿瘤标志物,术中所见及术后病理。治疗方法:排除禁忌后行手术治疗,术后予以对症治疗。临床转归:患者术后恢复可,无发热,无阴道流血等不适。适合阅读人群:妇科,普外科,影像科。
Abstract: Summary of case history: A 48-year-old woman was admitted to our hospital due to “Lower ab-dominal pain for 2 weeks, palpable pelvic mass for 1 week”. 2 weeks ago, she presented with pro-gressively aggravated abdominal pain and diarrhea without fever during menstruation. Diarrhea Symptoms disappeared after 3 days. One week ago, the patient had palpable mass in the lower ab-domen, hard and flat umbilicus, accompanied by a sense of anal distension. The pelvic ultraso-nograms illustrated complex pelvic masses highly suspicious for neoplasm. Surgical exploration revealed tubo-ovarian abscess. Antibiotic anti-infection treatment was given after operation. Symptoms and signs: There was a little white secretion in vagina, no peculiar smell. The cervix was smooth and tough. Solid and hardly removable mass was palpable in the pelvic cavity with a size of about 20*20 cm, bilateral reaching pelvic walls, the upper flat to the umbilical cord, the lower reaching uterine rectum depression, while bilateral adnexal areas were untouched. Digital rectal examination: hard mass can be touched at 3 cm into the finger, immovable and unclear boundary, convex to the rectum. No blood stained on the back finger sleeve. Diagnostic methods: Based on auxiliary examination results such as gynecological ultrasound, pelvic magnetic resonance imaging and tumor markers, the diagnosis was confirmed by intraoperative findings and postoperative pa-thology. Therapeutic methods: After eliminating contraindications, surgical treatment was per-formed. And symptomatic treatment was given after surgery. Clinical outcomes: The patient has recovered after treatment without fever, vaginal bleeding and other discomfort. It’s suitable for reading: department of gynecology, general surgery and imaging.
文章引用:焦玉雪, 冷喆, 赵婕, 黄煜. 输卵管–卵巢脓肿误诊为卵巢恶性肿瘤一例[J]. 临床医学进展, 2022, 12(5): 4864-4869. https://doi.org/10.12677/ACM.2022.125705

参考文献

[1] Zhang, Z., Bullock, R.G. and Fritsche, H. (2019) Adnexal Mass Risk Assessment: A Multivariate Index Assay for Ma-lignancy Risk Stratification. Future Oncology, 15, 3783-3795. [Google Scholar] [CrossRef] [PubMed]
[2] Curry, A., Williams, T. and Penny, M.L. (2019) Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. Ameri-can Family Physician, 100, 357-364.
[3] Zhang, M., Cheng, S., Jin, Y., et al. (2021) Roles of CA125 in Diagnosis, Prediction, and Oncogenesis of Ovarian Cancer. Biochimica et Biophysica Acta—Reviews on Cancer, 1875, Article ID: 188503. [Google Scholar] [CrossRef] [PubMed]
[4] Yeoh, M. (2015) Investigation and Management of an Ovarian Mass. Australian Family Physician, 44, 48-52.
[5] Hada, A., Han, L.P., Chen, Y., et al. (2020) Comparison of the Predictive Performance of Risk of Malignancy Indexes 1-4, HE4 and Risk of Malignancy Algorithm in the Triage of Adnexal Masses. Journal of Ovarian Research, 13, 46. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, H., Liu, P., Xu, H., et al. (2021) Early Diagonosis of Ovarian Cancer: Serum HE4, CA125 and ROMA Model. American Journal of Translational Research, 13, 14141-14148.
[7] Dochez, V., Caillon, H., Vaucel, E., et al. (2019) Biomarkers and Algorithms for Diagnosis of Ovarian Cancer: CA125, HE4, RMI and ROMA, a Review. Journal of Ovarian Research, 12, Article No. 28. [Google Scholar] [CrossRef] [PubMed]
[8] Meys, E.M., Kaijser, J., Kruitwagen, R.F., et al. (2016) Subjective Assessment versus Ultrasound Models to Diagnose Ovarian Cancer: A Systematic Review and Meta-Analysis. Europe-an Journal of Cancer, 58, 17-29. [Google Scholar] [CrossRef] [PubMed]
[9] Thomassin-Naggara, I., Poncelet, E., Jalaguier-Coudray, A., et al. (2020) Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratifi-cation of Sonographically Indeterminate Adnexal Masses. JAMA Network Open, 3, e1919896. [Google Scholar] [CrossRef] [PubMed]
[10] Granberg, S., Gjelland, K. and Ekerhovd, E. (2009) The Management of Pelvic Abscess. Best Practice & Research Clinical Obstetrics & Gynaecology, 23, 667-678. [Google Scholar] [CrossRef] [PubMed]
[11] Kinay, T., Unlubilgin, E., Cirik, D.A., et al. (2016) The Value of Ultrasonographic Tubo-Ovarian Abscess Morphology in Predicting Whether Patients Will Require Surgical Treatment. International Journal of Gynecology & Obstetrics, 135, 77-81. [Google Scholar] [CrossRef] [PubMed]
[12] Hakim, J., Childress, K.J., Hernandez, A.M., et al. (2019) Tubo-Ovarian Abscesses in Nonsexually Active Adolescent Females: A Large Case Series. Journal of Adolescent Health, 65, 303-305. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, K.Y., Tseng, J.Y. and Yang, C.Y. (2019) Tubo-Ovarian Abscess with Sepsis in a Nonagenarian Woman: A Case Report and Literature Review. BMC Women’s Health, 19, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, T., Li, W., Wu, X., et al. (2016) Tubo-Ovarian Abscess (with/without Pseudotumor Area) Mimicking Ovarian Malignancy: Role of Diffusion-Weighted MR Imaging with Apparent Diffusion Coefficient Values. PLoS ONE, 11, e0149318. [Google Scholar] [CrossRef] [PubMed]
[15] Demirtas, O., Akman, L., Demirtas, G.S., et al. (2013) The Role of the Serum Inflammatory Markers for Predicting the Tubo-Ovarian Abscess in Acute Pelvic Inflammatory Disease: A Single-Center 5-Year Experience. Archives of Gynecology and Obstetrics, 287, 519-523. [Google Scholar] [CrossRef] [PubMed]
[16] Chappell, C.A. and Wiesenfeld, H.C. (2012) Pathogenesis, Diag-nosis, and Management of Severe Pelvic Inflammatory Disease and Tuboovarian Abscess. Clinical Obstetrics and Gy-necology, 55, 893-903. [Google Scholar] [CrossRef
[17] Inal, Z.O., Inal, H.A. and Gorkem, U. (2018) Experience of Tubo-Ovarian Abscess: A Retrospective Clinical Analysis of 318 Patients in a Single Tertiary Center in Middle Turkey. Surgical Infections (Larchmt), 19, 54-60. [Google Scholar] [CrossRef] [PubMed]
[18] Goje, O., Markwei, M., Kollikonda, S., et al. (2021) Outcomes of Min-imally Invasive Management of Tubo-Ovarian Abscess: A Systematic Review. Journal of Minimally Invasive Gynecolo-gy, 28, 556-564. [Google Scholar] [CrossRef] [PubMed]
[19] Shigemi, D., Matsui, H., Fushimi, K., et al. (2019) Laparoscopic Compared with Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess. Obstetrics & Gyne-cology, 133, 1224-1230. [Google Scholar] [CrossRef
[20] Kudesia, R. and Gupta, D. (2011) Pelvic Salmonella Infec-tion Masquerading as Gynecologic Malignancy. Obstetrics & Gynecology, 118, 475-477. [Google Scholar] [CrossRef